Accumulating evidence indicates that FLNA dysregulation is implicated in various cancer types, including breast cancer (Xu et al., 2010), parathyroid carcinoma (Storvall et al., 2021), adrenocortical carcinoma (Esposito et al., 2025), and prostate cancer (Di Donato et al., 2021). Here, FLNA is linked to prostate cancer.